Product Information

FONDAPARINUX 7.5 MG/0.6 ML SYR is a generic product labeled by Eugia US LLC, priced at $42.7121 per ML under NDC 55150023210. Its NADAC has been published 347 times since Feb 27, 2019.

FDA first approved this application on Dec 26, 2017. Its Orange Book therapeutic-equivalence code is AP.

FONDAPARINUX 7.5 MG/0.6 ML SYR

FONDAPARINUX SODIUM
$42.7121per ML

Strength

7.5 mg/.6mL

Manufacturer

Eugia US LLC

NDC

55150023210

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

FONDAPARINUX SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206918

FDA Approved

12/26/2017

TE Code

AP

On Market Since

12/26/2017

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price Statistics

The NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has been published 347 times since Feb 27, 2019, and over the history we have for it it has declined 47.1%. The table below summarizes its recorded NADAC range and movement.

Current price$42.7121 per ML
All-time high$80.8102 (Jun 12, 2019)
All-time low$34.9283 (Jun 19, 2024)
52-week high$43.4533
52-week low$38.5660
Median price$57.4547
Average price$56.3626
Largest weekly change+27.9% (Jul 17, 2024)
Weeks tracked347
Tracking sinceFeb 27, 2019

Price History

1W

+0.1%

1M

+0.1%

3M

-1.5%

6M

+2.0%

1Y

+7.9%

3Y

-25.7%

5Y

-37.8%

All

-47.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FONDAPARINUX SODIUM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of FONDAPARINUX 7.5 MG/0.6 ML SYR?

The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 7.5 MG/0.6 ML SYR, manufactured by Eugia US LLC, is $42.7121 per ML (NDC 55150023210), effective Aug 19, 2026.

How has the price of FONDAPARINUX 7.5 MG/0.6 ML SYR changed over time?

Over the history we have for it, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has declined 47.1%. It has been tracked across 347 weekly CMS publications since Feb 27, 2019.

What are the highest and lowest recorded NADAC prices for FONDAPARINUX 7.5 MG/0.6 ML SYR?

Since Feb 27, 2019, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has ranged from a low of $34.9283 (Jun 19, 2024) to a high of $80.8102 (Jun 12, 2019), with a median of $57.4547 per ML.

Are there cheaper alternatives to FONDAPARINUX 7.5 MG/0.6 ML SYR?

No other NADAC-published product currently shares the active ingredient and strength of FONDAPARINUX 7.5 MG/0.6 ML SYR in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures FONDAPARINUX 7.5 MG/0.6 ML SYR?

FONDAPARINUX 7.5 MG/0.6 ML SYR (NDC 55150023210) is labeled by Eugia US LLC, and CMS classifies it as a generic product.